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1032 The Journal of Thoracic and CardObjective: We sought to determine the impact of preoperative or postoperative atrial
fibrillation on survival, stroke, and cardiac function after mitral valvuloplasty for
mitral regurgitation.
Methods: Between 1991 and 2003, 1026 patients with nonischemic/noncardiomy-
opathy mitral valve regurgitation underwent mitral valve plasty in 3 centers; 663
patients remained in sinus rhythm (group A), and 363 patients had atrial fibrillation
or flutter preoperatively (group B) with concomitant maze procedures (group BM,
n  163) or without maze procedures (group BN, n  200).
Results: Eight-year freedom from cardiovascular-related death was better in group
A (99.3%) than group B (BM: 96.9%, BN: 81.6%) (P  .001) and also better in
group BM than group BN (P  .007). The adjusted hazard ratio of group B versus
group A for preoperative differences was 5.1 (95% confidence interval: 1.8-14.8).
Eight-year freedom from stroke was better in group A (99.2%) than group B (BM:
98.2%, BN: 82.6%) (P  .001) and also better in group BM than group BN (P 
.001). Patients with preoperative atrial fibrillation had larger left atria and left
ventricular systolic dimensions. The adjunct maze procedure improved left ventric-
ular systolic dimensions over mitral repair alone (group A vs B: P  .359; group
BM vs BN: P  .001).
Conclusion: Preoperative permanent/persistent atrial fibrillation was associated with
a dilated left atrium and reduced left ventricular function in patients with mitral
regurgitation. Including the maze procedure with mitral repair improved survival,
late cardiac function, and freedom from late stroke.
Optimal timing of mitral valve repair for patients with chronic mitral regur-gitation is critical and remains controversial.1 Current American HeartAssociation/Americal College of Cardiology guidelines for surgery have
focused on the onset of symptoms and left ventricular dysfunction.2 However,
waiting until a patient is in New York Heart Association (NYHA) class III or for a
reduction of ventricular ejection fraction may result in increased postoperative
morbidity and mortality.3
Atrial fibrillation (AF) commonly accompanies mitral regurgitation and has been
identified as an independent predictor of overall survival and late stroke after
surgery for mitral regurgitation.4 However, there are conflicting reports regarding
the impact of AF on late outcome after mitral valve surgery.5,6 Moreover, little is
known regarding the influence of preoperative and postoperative AF on survival and
late cardiac function after mitral valve repair.
Recent studies indicated that combining the maze procedure and mitral valve repair
reduces the incidence of late stroke,7,8 but the impact of an adjunct maze procedure on
iovascular Surgery ● May 2005
Bando et al Surgery for Acquired Cardiovascular Disease
A
CDlate survival and cardiac function remains unclear. The pur-
pose of this study was to determine the impact of preoperative
and postoperative AF on survival, cardiovascular-related
deaths, stroke, and cardiac function after mitral valve repair for
nonischemic mitral regurgitation.
Patients and Methods
Between January 1991 and December 2003, 1026 consecutive
patients underwent mitral valve repair at 3 centers: National Car-
diovascular Center (n  332), Sakakibara Heart Institute (n 
379), and Kobe Central City Hospital (n  315). Thirty-three
patients who were initially planned to undergo mitral valve repair
but instead underwent mitral valve replacement at initial surgery
were excluded from the study. We reviewed data from the oper-
ative notes, clinical case histories, and laboratory investigations,
including electrocardiograms, echocardiograms, and cardiac cath-
eterization reports. Institutional review board approval for this
study was obtained in each institution. Follow-up data were col-
lected from each institution’s outpatient records and correspon-
dence with referring physicians. Follow-up data for more than 6
months after operation were available in all patients. The mean
follow-up period was 4.3 years, and 8 patients were lost to fol-
low-up within 5 years. Morbid events were analyzed for both the
early (in hospital) and late (after discharge) periods.
Definitions
Preoperative AF was defined as permanent/persistent/paroxys-
mal AF according to American Heart Association/Americal
College of Cardiology guidelines.9 Preoperative stroke was
defined as cerebral thromboembolism diagnosed by a neurolo-
gist and confirmed by computed tomography scan and was
clearly differentiated from transient ischemic attack. Transient
ischemic attacks were not counted as strokes in this study.
Causes of death were divided as all cause of deaths and car-
diovascular-related deaths. Cardiovascular-related deaths in-
cluded death from congestive heart failure, arrhythmia, cerebral
infarction, cerebral bleeding, and other cardiovascular-related
events. We chose to analyze the recurrence of arrhythmia after
the first 30 days because early postoperative AF might be
caused by different mechanisms than those of permanent/per-
sistent AF. Electrocardiography was performed in each patient
within the first 30 days, 6 months after surgery, and at the
annual clinic visit of referring physicians or surgeons.
Patients
Demographic data and preoperative cardiac information are given
in Table 1. The patients were divided into groups as follows: 663
patients in sinus rhythm (group A) and 363 patients in permanent
AF (n 310), persistent AF (n 28), recurrent paroxysmal AF (n
 15), or atrial flutter (n  10) preoperatively (group B). In group
B, a concomitant maze procedure was performed in 163 patients
(group BM), whereas the remaining 200 patients (group BN) did
not undergo a maze procedure because of the surgeon’s preference
(eg, the maze procedure was omitted in complex mitral vale repair
or severe congestive heart failure), documented duration of AF
(20 years), or emergency surgery.
The Journal of ThoracicSurgical Indications and Techniques
Table 2 summarizes the surgical pathology of the mitral valve.
Ischemic mitral regurgitation and dilatated cardiomyopathy were
excluded from this study. Although combined tricuspid valve
surgery and atrial or ventricular septal defect closure were in-
cluded, patients who underwent combined coronary artery bypass,
aortic valve surgery, or aortic surgery were excluded from the
study.
Repair of the mitral valve was performed by techniques de-
scribed by Carpentier10 and David and colleagues.11 Prolapse of
the mid-scallop of the posterior leaflet was corrected by resection;
prolapse of the anterior leaflet was corrected by chordal replace-
ment with polytetrafluoroethylene (Gore-Tex; W. L. Gore and
Associates, Inc, Flagstaff, Ariz) sutures.10,11 Commissural pro-
lapse was repaired by resection and sutures with or without the
Kay technique. Patients with longstanding mitral regurgitation and
dilated mitral annulus underwent annuloplasty with Carpentier,
Duran, or Cosgrove rings, or a handmade ring made by autologous
pericardium.12 In patients undergoing the maze procedure, 3 dif-
ferent techniques were used: Cox maze III (n 18), Kosakai maze
(n  47), and cryo-maze procedure (n  98); 5 patients in atrial
flutter underwent only the right side of the cryo-maze procedure.
The cryo-maze procedure was modified from the Kosakai maze
procedure to use cryoablation around the left pulmonary veins,
avoiding the incision encircling all 4 orifices of the pulmonary
TABLE 1. Preoperative clinical characteristics
A
(n  663)
BM
(n  163)
BN
(n  200) P value
Gender (male/female) 396/267 109/54 129/71 .166
Age (y) (range/median) 18-82/56 22-79/60 19-78/62 .001
Hypertension 58 (9%) 9 (6%) 29 (15%) .009
Diabetes 15 (2%) 1 (1%) 6 (3%) .278
Stroke history 19 (3%) 8 (5%) 13 (7%) .051
Renal failure 5 (1%) 1 (1%) 2 (1%) .910
LA thrombus 8 (1%) 5 (3%) 0 (0%) .033
NYHA class
I 69 (10%) 10 (6%) 14 (7%) .001
II 369 (56%) 79 (49%) 88 (44%)
III 160 (24%) 54 (33%) 77 (39%)
IV 36 (5%) 13 (8%) 15 (8%)
Unknown 29 (4%) 7 (4%) 6 (3%)
LAD
60 mm 579 (87%) 82 (50%) 137 (69%) .001
60 mm 16 (2%) 72 (44%) 58 (29%)
Unknown 68 (10%) 9 (6%) 5 (3%)
LVDs
40 mm 439 (66%) 76 (47%) 108 (54%) .001
40 mm 152 (23%) 70 (43%) 86 (43%)
Unknown 72 (11%) 17 (10%) 6 (3%)
% FS
25% 24 (4%) 24 (15%) 31 (16%) .001
25% 573 (86%) 130 (80%) 164 (82%)
Unknown 66 (10%) 9 (6%) 5 (3%)
LA, Left atrial; NYHA, New York Heart Association; LAD, left atrial dimen-
sion; LVD, left ventricular dimension; FS, fractional shortening.veins.8,13
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Evaluation
Transthoracic echocardiograms were performed before surgery,
at discharge, and annually thereafter. In the majority of the
patients, intraoperative echocardiography was performed at the
completion of the surgery. Successful mitral valve repair was
defined as a maximal mitral regurgitant area less than 2 cm.2,14
Postoperative echocardiographic examinations were performed
during a follow-up period of 4.3  3.2 years after operation.
For those patients who died or underwent reoperation during the
follow-up period, the last echocardiographic data before death
or the secondary surgical intervention were used.13
Postoperative Anticoagulation
All patients were given warfarin sodium for the first 3 postoper-
ative months. Permanent anticoagulation was recommended if AF
persisted after operation. In case autologous pericardium was used
as a ring annuloplasty, systemic anticoagulation was not performed
for patients in sinus rhythm.
Statistics
All values were expressed as mean  SD or percentages. The 2
or Kruskal-Wallis test was used for comparison. The adjusted
hazard ratio (HR) of group B versus group A for death and
stroke was estimated by using a Cox proportional hazard model
with variables: gender; age; hypertension; diabetes; stroke his-
tory; NYHA class; preoperative left atrial dimension (LAD)
(60 mm/60 mm); preoperative left ventricular dimension
(LVD) (40 mm/40 mm); years of operation; rheumatic,
degenerative, infective endocarditis; anterior leaflet involved;
and institution. To estimate the adjusted HR of group BN
against BM, the propensity score15 was used in the Cox pro-
portional hazard model. The propensity score (the probability of
the maze procedure was combined with that of mitral valve
TABLE 2. Surgical pathology and concomitant surgery
A
(n  663)
BM
(n  163)
BN
(n  200)
P
value
Cause
Degenerative 492 (74%) 111 (68%) 161 (81%) .001
Infective endocarditis 127 (19%) 8 (5%) 18 (9%)
Rheumatic 24 (4%) 30 (18%) 18 (9%)
Congenital 20 (3%) 14 (9%) 3 (2%)
Anterior leaflet involved
Yes 265 (40%) 49 (30%) 97 (49%) .002
No 398 (60%) 114 (70%) 103 (52%)
Concomitant surgery
TAP 48 (7%) 48 (29%) 59 (30%) .001
ASD/VSD repair 17 (3%) 13 (8%) 3 (2%) .001
Year of operation
1991-1995 170 (26%) 42 (26%) 49 (25%) .263
1996-2000 287 (43%) 73 (45%) 110 (55%)
2001-2003 206 (31%) 48 (29%) 41 (21%)
TAP, tricuspid annuloplasty; ASD, atrial septal defect; VSD, ventricular
septal defect.repair in patients with AF) was estimated by multivariable
1034 The Journal of Thoracic and Cardiovascular Surgery ● Malogistic regression by use of the same variables in the Cox
proportional hazard model. Survival and freedom from stroke
and AF were estimated by using the Kaplan-Meier method.
Survival curves were compared with the log-rank test. Echo-
cardiographic variables were compared by t test as percentage
changes from preoperation to last follow-up.
Results
Patient Background and Surgical Techniques
Patient characteristics among the 3 cohorts are shown in
Table 1. Patients in group A were younger and had better
NYHA functional class, smaller LAD, and smaller left
ventricular systolic dimension (LVDs) when compared with
those with preoperative AF (groups BN and BM). Further-
more, patients with infective endocarditis were more likely
to be in sinus rhythm, whereas rheumatic patients had a
higher incidence of AF before surgery. Among patients with
preoperative AF, the use of a concomitant maze procedure
was significantly less when anterior leaflet repair was in-
volved. Finally, concomitant tricuspid valve surgery was
required more frequently in groups BN and BM than group
A (Table 2).
Postoperative Morbidity and Mortality
Hospital death occurred in 15 patients (1.5%); the causes of
deaths included respiratory failure (n  6), congestive heart
failure (n  4), multisystem organ failure (n  3), and others
(n  2). Postoperative complications included bleeding (15),
respiratory failure (13), renal failure (6), infection (5), low
output syndrome (5), cerebral infarction (4), myocardial infarc-
tion (3), left ventricular rupture (3), and liver failure (1).
Freedom from Reoperation and Durability of Mitral
Valve Repair
Only 22 patients (3.3%) in group A, 9 patients (4.5%) in
group BN, and 7 patients (4.3%) in group BM required
reoperation (Appendix 1). Moreover, only 4% to 9% of
patients had more than moderate regurgitation in the
latest follow-up over 2 years after surgery (Appendix 2).
Survival and Late Mortality
All patients were followed for at least 6 months after oper-
ation. Actuarial survival of group B was significantly lower
than group A, and survival of group BN was significantly
lower than group BM (Figure 1). Eight-year survivals were
99.3% (A), 96.9% (BM), and 81.6% (BN). Similar trends
were observed in freedom from cardiovascular-related
deaths (Figure 2).
There were 46 late deaths. The causes of late deaths
included cerebral infarction (14), congestive heart failure
(8), malignancy (8), cerebral bleeding (4), respiratory fail-
ure (2), multisystem organ failure (n 1), and others (9). Of
note, 12 patients remained in AF or had frequent paroxys-
mal AF after surgery and died of thromboembolic events.
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among the groups, the Cox hazard model was applied to
analyze the independent risk factors. The adjusted HR of
cardiovascular-related deaths for group B versus group A
was 5.1 (95% confidence interval [CI]: 1.8-14.8). The risk
for late mortality increased with advanced age (HR: 2.5,
95% CI: 1.4-4.3, 10-year unit) and a preoperative enlarged
LAD (HR: 3.3, 95% CI: 1.2-9.0) (Table 3), although the
adjusted HR of group BN versus group BM did not reach a
significant level (HR: 2.7, 95% CI: 0.4-18.0).
Figure 1. Overall survival.Figure 2. Freedom from cardiovascular-related deaths.
The Journal of ThoracicIncidence of Stroke After Mitral Valve Repair
Twenty-six patients had a late stroke, 23 of whom were
aged more than 60 years. Eight-year freedom from stroke
was better in group A (99.2%) compared with group B (BM:
98.2%, BN: 82.6%, P  .001) (Figure 3).
The adjusted HR of stroke incidence for group B versus
group A was 8.7 (95% CI: 2.7-27.9). Risk for late mortality
increased with advanced age (HR: 3.4, 95% CI: 1.9-6.4,
10-year unit) (Table 4). For group BN versus group BM, the
HR was significantly higher at 7.6 (95% CI: 1.2-47.7).
Recurrence of AF
We chose to analyze recurrence of arrhythmia after the first
30 days because early postoperative AF might be caused by
different mechanisms than those of permanent/persistent
AF. In patients with preoperative sinus rhythm (group A),
94.2% (92.4%-96.1%) of patients maintained sinus rhythm
TABLE 3. Results of Cox analysis for cardiac-related death
Variables* Hazard ratio 95% CI P value
Group B vs A 5.12 1.77-14.80 .003
Age 2.48 1.44-4.27 .001
NYHA (I, II/III, IV) 2.10 0.84-5.23 .114
Preoperative LAD
(60 mm/60 mm)
3.34 1.24-8.99 .017
Infective endocarditis 3.03 0.58-15.78 .189
Institution A vs C 3.48 1.01-11.97 .049
B vs C 3.33 1.01-11.03 .049
Group BN vs BM† 2.73 0.41-18.01 .298
CI, Confidence interval; NYHA, New York Heart Association; LAD, left atrial
dimension. *Variables with P value  .20 were presented. †Adjusted by
propensity score for maze procedure.Figure 3. Freedom from stroke.
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itant maze procedure for preoperative AF (group BM),
freedom from AF at 8 years was 80.4% (72.4%-88.3%).
Freedom from AF in the group undergoing mitral valvulo-
plasty alone (group BN) at 8 years was 24.3% (18.1%-
30.5%) (Figure 4).
Impact of Postoperative AF on Late Mortality and
Stroke
Because the incidence of postoperative AF was different
among the 3 groups, freedom from cardiac-related death and
stroke was analyzed separately by postoperative rhythm 1
month after surgery.
In regard to the impact of postoperative rhythm, free-
dom from cardiac-related death in patients with post-
operative regular rhythm was 98.9% (97.9%-100%)
compared with 82.1% in those with permanent/persistent
TABLE 4. Results of Cox analysis for stroke
Variables* Hazard ratio 95% CI P value
Group B vs A 8.69 2.71-27.89 .001
Age 3.37 1.85-6.13 .001
Preoperative LAD
(60 mm/60 mm)
2.24 0.79-6.34 .129
Preoperative LVDs
(40 mm/40 mm)
0.47 0.17-1.25 .129
Institution A vs C 1.27 0.32-5.11 .736
B vs C 2.84 0.88-9.18 .082
Group BN vs BM† 7.63 1.22-47.66 .030
CI, Confidence interval; LAD, left atrial dimension; LVD, left ventricular
dimension. *Variables with P value  .20 were presented. †Adjusted by
propensity score for maze procedure.Figure 4. Freedom from atrial fibrillation after surgery.
1036 The Journal of Thoracic and Cardiovascular Surgery ● MaAF (73.5%-90.7%) (Figure 5). Freedom from stroke in
patients with postoperative regular rhythm was 99.4%
(98.7%-100%) compared with 81.0% (73.2%-88.7%)
in those withpba permanent/persistent AF after surgery
(Figure 6). The summary of stroke- and cardiac-related
deaths stratified by postoperative AF is depicted in Ap-
pendix 3.
Comparison of Preoperative and Postoperative
Echocardiographic Variables
Before surgery, patients with permanent/persistent AF had a
larger LAD than patients in sinus rhythm (group A: 45.7 
Figure 5. Freedom from cardiovascular-related deaths stratified
by postoperative rhythm. AF, Atrial fibrillation.
Figure 6. Freedom from stroke stratified by postoperative rhythm.
AF, Atrial fibrillation.
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mm). After surgical intervention, the LAD size decreased
but enlarged again in patients with permanent/persistent AF
after surgery (Table 5). Similarly, left ventricular end-dia-
stolic dimension and LVDs decreased after mitral repair in
all groups. However, in patients who did not undergo a
maze procedure (group BN), late recurrent enlargement of
LAD was observed, whereas LAD remained small in groups
A and BM late after surgery (2 years). Furthermore, a
significant improvement of LVDs was observed in group
BM compared with BN.
Discussion
In the current study, we elucidated the impact of preopera-
tive and postoperative AF and an adjunct maze procedure
on late survival, stroke, and change in echocardiographic
indices after mitral valvuloplasty.
This multicenter retrospective study suggests that mitral
valve repair before development of AF may have a signif-
icantly positive impact on survival and freedom from stroke
and improved late cardiac function after surgical interven-
tion. Before surgery, patients in group A generally had
smaller LAD and LVDs compared with group B. Accord-
ingly, patients in group A had excellent 8-year freedom
from cardiovascular-related death (99.3%) and freedom
from stroke (99.2%). In contrast, patients with preoperative
AF (group B) had significantly lower freedom from cardio-
vascular-related deaths (BM: 96.9%, BN: 81.6%) and stroke
(BM: 98.2%, BN: 82.6%) 8 years after surgery. Group BM
(with adjunct maze procedure) showed similar high freedom
from cardiovascular-related death (96.9%) and stroke
(98.2%) compared with group A. Thus, the maze procedure
may help to improve survival and reduce the incidence of
stroke when combined with mitral valve repair as previ-
TABLE 5. Echocardiographic variables
Variables Preoperative
Discharge
percentage chan
LAD (mm)
Group A 45.7 7.2 (595) 17.0 14.0 (47
Group BM 57.8 8.2 (154) 20.9 11.4 (79
Group BN 53.9 10.7 (195) 18.8 14.6 (17
LVDd (mm)
Group A 57.3 7.5 (596) 17.7 10.5 (49
Group BM 58.6 9.5 (146) 12.6 12.7 (75
Group BN 58.9 7.6 (194) 14.2 12.2 (18
LVDs (mm)
Group A 36.0 6.9 (591) 7.0  17.4 (48
Group BM 39.1 7.8 (146) 4.3  16.3 (73
Group BN 39.1 7.8 (194) 6.2  19.8 (17
Number of patients is given in parentheses. LAD, Left atrial dimension; LV
dimension.ously reported.16,17
The Journal of ThoracicBecause significant differences were observed in pa-
tient demographics and clinical history, the risk factors
for late death and stroke were analyzed with the Cox
hazard model. Preoperative AF, advanced age, and larger
LAD predicted cardiovascular-related mortality late after
surgery (Table 3). When groups BM and BN were com-
pared, however, the effect of the maze procedure on
survival was not significant when the propensity score
was used (Table 3). Preoperative AF and older age were
the significant risk factors for late stroke after mitral
valve repair. The effect of the maze procedure in reduc-
ing the incidence of stroke was confirmed by the Cox
hazard model with the propensity score (Table 4). These
results suggest that advanced age and omission of the
maze procedure in patients with AF are the independent
risk factors for stroke after mitral valve repair.
Because 27 patients in group BM had permanent/persis-
tent AF after the maze procedure and mitral valve repair, the
impact of postoperative rhythm on survival and stroke was
analyzed separately. As shown in Figures 5 and 6, freedom
from cardiovascular-related death and stroke was signifi-
cantly lower in patients with postoperative AF compared
with those in sinus rhythm 1 month after surgery.18 Overall,
26 patients had stroke after mitral valve repair. Twenty of
those patients were in group BM and had AF both before
and after surgery. Of note, 11 (11/20  55%) of those
patients were not anticoagulated or were inadequately anti-
coagulated (international normalized ratio  1.8) with war-
farin at the time of their strokes. The importance of main-
taining adequate anticoagulation and ensuring compliance
with warfarin in patients with AF deserves reemphasis.19
This study was also designed to examine the effect of
preoperative rhythm and the maze procedure on late cardiac
function. In all groups, LAD decreased after mitral valve
Last follow-up P value
percentage change A:BMBN BM:BN
11.3 15.3 (313) .001
23.3 12.6 (122) .001
7.1  127.8 (105)
15.5 13.7 (311) .006
11.5 16.0 (102) .574
12.6 12.4 (102)
15.0 17.1 (310) .359
17.9 17.8 (102) .001
9.1  19.6 (102)
ft ventricular end-diastolic dimension; LVDs, Left ventricular end-systolicge
0)
)
8)
2)
)
0)
5)
)
8)
Dd, Lerepair. However, in patients who did not undergo a maze
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was observed, whereas LAD remained small in groups A
and BM late after surgery (2 years). Furthermore, signif-
icant improvement of LVDs was observed in group BM
when compared with group BN. Thus, left ventricular func-
tion may be improved by restoring sinus rhythm after the
maze procedure. Although a positive impact of sinus
rhythm on cardiac function was observed, we believe these
findings are still preliminary because all of the echocardi-
ography indices were load-dependent. Thus, these data may
be directly influenced by the alterations in preload and
afterload, and the vagaries of medical management. Obvi-
ously, further study is necessary to precisely analyze the
impact of preoperative and postoperative AF on cardiac
function before and after mitral valve repair.
This retrospective multi-institutional study has several
limitations. First, the significant number of differences in
preoperative background made comparisons difficult among
the groups. Patients in sinus rhythm were younger, had
better NYHA functional class, and had smaller LAD and
LVDs when compared with those with preoperative AF.
Thus, it is difficult to precisely blame AF for the decreased
survival, reduced freedom from stroke, and inadequate re-
covery of late cardiac function.
Second, the decision to perform an adjunct maze pro-
cedure was primarily according to surgeon preference.
Because the Cox maze procedure prolongs cardiopulmo-
nary bypass time, the maze procedure was omitted when
patients had complex mitral regurgitation or severe left
ventricular dysfunction. However, the cryo-maze tech-
nique requires only 20 to 25 minutes of additional aortic
crossclamp time, so the adjunct maze procedure is cur-
rently performed in the majority of mitral repair cases.20
The development of easier “mini-maze” or pulmonary
vein isolation techniques with better energy sources may
further improve the adaptability of this technique.21
Third, although the length of AF before surgery may have
a significant impact on preoperative cardiac function,
these indices were not examined because the period of
AF before surgery was not clear in 40% of the patients.
Fourth, information on left atrial contraction before and
after surgery was available in only a few of the patients
who underwent maze procedures; thus this information
was also not incorporated in this study.22
Conclusion
Preoperative AF was associated with reduced survival and
freedom from late stroke after surgery.23 The addition of a
maze procedure improved late cardiac function, survival,
and freedom from late stroke. The development of easier
“mini-maze” or pulmonary vein isolation techniques with
other energy sources may benefit a significant number of
1038 The Journal of Thoracic and Cardiovascular Surgery ● Mapatients with AF who require extensive and complex mitral
valve surgery.24
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Appendix 1. Freedom from reoperation
Freedom from reoperation Reoperation
n (%)Year 1 Year 5 Year 8
Group A 98.3% (97.3-99.3%) 96.3% (94.4-98.2%) 93.5% (90.2-96.3%) 22/663 (3.3)
Group BM 98.1% (96.0-100%) 94.3% (89.5-99.1) 91.7% (84.9-98.5%) 7/163 (4.3)
Group BN 99.5% (98.5-100%) 96.3% (93.0-99.5%) 86.7% (76.6-96.7%) 9/200 (4.5)
Appendix 2. Mitral regurgitation at last follow-up
MR, n (%)
0 1 2 3 4
Group A (n  325) 143 (44.0) 130 (40.0) 36 (11.1) 13 (4.0) 3 (0.9)
Group BM (n  120) 37 (30.8) 61 (50.8) 17 (14.2) 3 (2.5) 2 (1.7)
Group BN (n  102) 42 (41.2) 30 (29.4) 21 (20.6) 6 (5.9) 3 (2.9)
MR, Mllitral regurgitation.
Appendix 3. Stroke and cardiac-related deaths stratified by postoperative atrial fibrillation and group
Postoperative AF: No Postoperative AF: Yes
Stroke
Cardiac-related
deaths Stroke
Cardiac-related
deaths
Group A (n  663) 2/626 (0.3%) 5/626 (0.8%) 2/37 (5.4%) 1/37 (2.7%)
Group BM (n  163) 0/137 (0%) 1/137 (0.7%) 2/26 (7.7%) 2/26 (7.7%)
Group BN (n  200) 0/50 (0%) 0/50 (0%) 20/150 (13.3%) 17/150 (11.3%)Discussion
Dr Kevin Accola (Orlando, Fla). I appreciated the opportunity to
review your article beforehand. Dr Bando and his colleagues have
extensive database experience relative to mitral surgical proce-
dures. They have contributed other reports to this association
regarding mitral valve procedures, associated stroke risk, and
atrial arrhythmias. Dr Bando now adds to this very informative
retrospective review of the impact on treatment of AF with
concomitant mitral valvuloplasty using various forms of the
maze procedure.
Basically, Dr Bando’s data demonstrate the statistically signif-
icant survival improvement at 8 years in patients remaining in
sinus rhythm compared with those patients who remain in AF after
mitral valvuloplasty, therefore demonstrating a definitive benefit in
patients in whom a concomitant maze procedure was performed.
Also, freedom from cerebrovascular events was significant at 8
years if the patient was in sinus rhythm preoperatively or if a
concomitant maze procedure was performed, compared with those
patients who remained in AF regardless of anticoagulation status.LVD and subsequent left ventricular function compared with those
patients who remained in AF after mitral valvuloplasty.
Dr Bando, I have 4 questions for you. In your article you
differentiated between patients in group B as those in preoperative
AF or atrial flutter. How many of these patients were in atrial
flutter? Because it is often considered a right-sided phenomenon,
did this alter your approach to these patients and does this alter
your results?
Dr Bando. Question number 1 related to AF versus flutter. We
performed maze procedures in 163 patients; 10 of those were in
atrial flutter and 5 of those underwent a right-sided maze proce-
dure, but the remaining 158 patients underwent a full maze pro-
cedure.
Dr Accola. Have you evaluated newer technologies and energy
sources, and what are your experiences with these? Have you
incorporated these into your mitral valvuloplasty procedures?
Dr Bando. In this series, we did not include any of these new
devices, but we did have experience with a unipolar radiofre-
quency catheter in approximately 50 patients. Right now we still
have a question about the transmurality of these devices. A good
deal of laboratory data is now available to determine the efficacy
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CDof the new devices, such as from Dr Damiano’s laboratory. So our
policy is just to sit tight and wait and see which device will be the
best fit for us.
However, I totally agree with you. For this type of complex
mitral valve repair, the easier mini-maze or pulmonary vein iso-
lation with a better source will certainly increase the adaptability
of this technique and further benefit a significant number of pa-
tients.
Dr Accola. Dr Bando, in follow-up of the left ventricle dimen-
sional and functional improvement, did you recognize a decrease
in LAD, as you have stated, as well as improved atrial contractil-
ity? Did you see increasing atrial function when you went back and
reevaluated these patients with follow-up echocardiograms?
Dr Bando. There are certain limitations of this large retrospec-
tive study, especially, as you pointed out, only part of the patients’
data are available in terms of left atrial contractility, and newer
techniques, such as the radial approach described by Dr Nitta,
certainly will facilitate the contraction of the left atrium. However,
we do not have enough information from this retrospective large-
scale data.
Dr Accola. Last, Dr Bando, regarding anticoagulation, in your
article some of the patients who underwent the maze procedure
were not anticoagulated postoperatively if they remained in sinus
rhythm. Did any of these patients experience cerebrovascular
events, and if so, do you think differently now about anticoagu-
lating these patients, considering the numerous left atrial and
intra-atrial suture lines present? Would it be safer, possibly, to
anticoagulate these patients for a brief period of time postopera-
tively?
Dr Bando. Because we use rings in most patients, we continue
the anticoagulation for 3 months, and with the combined maze
procedure, those 3 months are the time we see the various types of
arrhythmia. If you do not see any types of arrhythmia, we stop the
anticoagulation at 3 months after surgery.
1040 The Journal of Thoracic and Cardiovascular Surgery ● MaHowever, we did see 2 patients who underwent a failed maze
procedure and had a stroke. At that time there was no left atrial
contraction confirmed by serial echocardiography. I think it is
important to follow these patients with serial echocardiography
whether there is left atrial contraction or not. If there is not, I
would recommend to continue anticoagulation.
Dr Eugene H. Blackstone (Cleveland, Ohio). Two concerns.
First, I believe that your data are consistent with many other pieces
of data that are coming out, so I do not have a concern about that,
but I have some concern about an apples and oranges comparison.
Is AF in your case a marker or a risk factor? Your groups are
all very different: You have large ventricles in group B, large atria
in group B, and older age in group B. All of these are factors that
are related to the outcomes that you have mentioned, and yet there
seems to be very little that you have done to try to make these
groups comparable.
I think the differences you are seeing are probably much larger
than real, and I wonder if you have tried to properly adjust the analysis
so we know much more truthfully what the differences are?
Dr Bando. Maybe I should have sent you the article before-
hand, Dr Blackstone. I did mention in my presentation that we
performed a multivariate analysis, a Cox hazard model using a
propensity score. So any possibility of risk factors or predictors
such as hypertension, stroke experience, diabetes, or AF was put
into the Cox hazard model, and then we analyzed the data. I would
not say we simply divided 3 different groups according to whether
this is in AF or not, but we did perform the Cox hazard model.
Dr David H. Adams (New York, NY). Can you just tell us
about your strategy for the left atrial appendage? Did you ligate it
and did you consider a reduction atrioplasty in selected patients?
Dr Bando. That is a very good point. These are 3 different
institutional studies, and I would say that the left atrial appendage
was ligated and closed in 65% of patients. However, in some of
those different institutions, they do not perform ligation. We would
especially not ligate patients in sinus rhythm.
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